High Prevalence of Isolates with Reduced Glycopeptide Susceptibility in Persistent or Recurrent Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus

Reduced susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates is considered a risk factor for failure of glycopeptide therapy. We compared the prevalences of MRSA isolates with reduced glycopeptide susceptibility in patients with versus without persi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Uçkay, Ilker, Bernard, Louis, Buzzi, Marta, Harbarth, Stephan, François, Patrice, Huggler, Elzbieta, Ferry, Tristan, Schrenzel, Jacques, Renzoni, Adriana, Vaudaux, Pierre, Lew, Daniel P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2012
Schlagworte:
Clinical Therapeutics
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3294919/
https://ncbi.nlm.nih.gov/pubmed/22155824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05808-11
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge